Skip to main content
TipRanks
Go Ultimate75% OFF

Inovio Pharmaceuticals (GBM) Stock Forecast & Price Target

6 Followers
See the Price Targets and Ratings of:

GBM Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Inovio Pharmaceuticals in the past 3 months

GBM Stock 12 Month Forecast

€5.71▲(350.12% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Inovio Pharmaceuticals in the last 3 months. The average price target is EUR 5.71 with a high forecast of EUR 7.21 and a low forecast of EUR 4.51. The average price target represents a 350.12% change from the last price of EUR 1.27.
Highest Price Target€7.21Average Price Target€5.71Lowest Price Target€4.51

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:GBM
Price TargetArticle
H.C. Wainwright€4.51buy255.35%UpsideReiterated11/12/26
Piper Sandler€7.21→€5.41buy326.43%UpsideReiterated11/11/26
Jefferies€2.70→€7.21buy468.57%UpsideAssigned11/06/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HROWHarrow Health
PLSEPulse Biosciences
DFTXDefinium Therapeutics
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Inovio Pharmaceuticals

3 Months
Edward Tenthoff
Edward TenthoffPiper Sandler
Success Rate5/10 ratings generated profit
50%
Average Return
+21.59%

Copying Edward Tenthoff's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +21.59% per trade.

1 Year
Edward Tenthoff
Edward TenthoffPiper Sandler
Success Rate4/10 ratings generated profit
40%
Average Return
+11.33%

Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +11.33% per trade.

2 Years
Edward Tenthoff
Edward TenthoffPiper Sandler
Success Rate5/10 ratings generated profit
50%
Average Return
+16.67%

Copying Edward Tenthoff's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +16.67% per trade.

GBM Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for GBM
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy13346
Buy00000
Hold23210
Sell00000
Strong Sell00000
total36556

In the current month, GBM has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GBM average Analyst price target in the past 3 months is 5.71.

GBM Financial Forecast

€-2€-1.25€-0.5€0.25€1Q1 2026Q3 2026Q4 2026
High€-0.10
Consensus€-0.12
Low€-0.14

GBM Earnings Forecast

Next quarter’s earnings estimate for GBM is -EUR 0.12 with a range of -EUR 0.14 to -EUR 0.10. The previous quarter’s EPS was -EUR 0.45. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€-1€67,545.8€135,092.5€202,639.3€270,186Q1 2026Q3 2026Q4 2026
High€136K
Consensus€45.2K
Low€0.00

GBM Sales Forecast

Next quarter’s sales forecast for GBM is EUR 45.20K with a range of EUR 0 to EUR 135.59K. The previous quarter’s sales results were EUR 270.19K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

GBM Stock Forecast FAQ

What is DE:GBM’s average 12-month price target, according to analysts?
Based on analyst ratings, Inovio Pharmaceuticals’s 12-month average price target is €5.71.
What is DE:GBM’s upside potential, based on the analysts’ average price target?
Inovio Pharmaceuticals has 350.12% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Inovio Pharmaceuticals a Buy, Sell or Hold?
Inovio Pharmaceuticals has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Inovio Pharmaceuticals’s share price target?
The average share price target for Inovio Pharmaceuticals is €5.71. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €7.21, and the lowest forecast is €4.51. The average share price target represents a 350.12% increase from the current price of €1.268.
What do analysts say about Inovio Pharmaceuticals?
Inovio Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Inovio Pharmaceuticals?
To buy shares of DE:GBM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.